A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)

BACKGROUND: Elevated serum levels of luteinizing hormone and slightly decreased serum levels of testosterone (mild Leydig cell insufficiency) is a common hormonal disturbance in testicular cancer (TC) survivors. A number of studies have shown that low serum levels of testosterone is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandak, Mikkel, Jørgensen, Niels, Juul, Anders, Lauritsen, Jakob, Kreiberg, Michael, Oturai, Peter Sandor, Helge, Jørn Wulff, Daugaard, Gedske
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494856/
https://www.ncbi.nlm.nih.gov/pubmed/28673265
http://dx.doi.org/10.1186/s12885-017-3456-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494856/
https://www.ncbi.nlm.nih.gov/pubmed/28673265
http://dx.doi.org/10.1186/s12885-017-3456-5

Ejemplares similares